• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/104 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulfur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/104

Total number of patents in this class: 63

10-year publication summary

8
4
2
9
4
3
2
2
2
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Adverio Pharma GmbH
44
7
Akaal Pharma Pty Ltd.
11
4
Mitsui Chemicals, Inc.
3187
3
Convert Pharmaceuticals SA
6
3
Barry University, Inc.
4
2
Huizhou Huahong New Material Co., Ltd.
4
2
Interquim, S.A.
51
2
Korea University Research and Business Foundation
2843
2
Kyungpook National University Industry-Academic Cooperation Foundation
1113
2
Onyx Therapeutics, Inc.
71
2
Glaxo Group Limited
4232
1
Centre National de La Recherche Scientifique
10163
1
Asahi Glass Company, Limited
2866
1
Commissariat à l'énergie atomique et aux energies alternatives
10715
1
The Trustees of Columbia University in the City of New York
3532
1
The Board of Trustees of the University of Illinois
2683
1
Academia Sinica
919
1
Agfa-Gevaert
281
1
Araxes Pharma LLC
89
1
Arrow Therapeutics Limited
13
1
Other owners 24